How elements of the Indian state purchase drugs

Harleen Kaur (), Ajay Shah and Siddhartha Srivastava ()
Additional contact information
Harleen Kaur: Independent Researcher
Siddhartha Srivastava: King's College, London

No 5, Working Papers from xKDR

Abstract: Quality problems in drug purchasing by Indian state agencies lie at the intersection of the field of drug quality in India and the field of government contracting in India. Improvements in the procedures used by state agencies when buying drugs can improve the working of public health care programs, and potentially also influence drug quality in the private market. The first step towards policy analysis and reform lies in careful description of how drug purchase works at present. In this paper, we describe how some elements of the Indian state buy drugs.

JEL-codes: H51 H57 H83 I18 (search for similar items in EconPapers)
Pages: 22 pages
Date: 2021-08
New Economics Papers: this item is included in nep-isf
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://papers.xkdr.org/papers/KSS2021_how_india_drugs_procurement.pdf First version, 2021 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:anf:wpaper:5

Access Statistics for this paper

More papers in Working Papers from xKDR
Bibliographic data for series maintained by Ami Dagli ().